Cystatin C, COVID-19 severity and mortality: a systematic review and meta-analysis

Angelo Zinellu1, Arduino A Mangoni2,3

  • 1Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Journal of Nephrology
|August 14, 2021
PubMed

Insights

Higher serum cystatin C levels indicate increased coronavirus disease 19 (COVID-19) severity and mortality risk. This marker aids in stratifying patients and guiding clinical decisions for better COVID-19 management.

Area of Science:

  • Biochemistry
  • Clinical Medicine
  • Epidemiology

Background:

  • Coronavirus disease 19 (COVID-19) poses significant clinical challenges.
  • Markers of renal dysfunction and inflammation, such as cystatin C, may aid in risk stratification for COVID-19 patients.

Purpose of the Study:

  • To systematically review and meta-analyze the association between serum cystatin C concentrations and clinical outcomes in COVID-19 patients.

Main Methods:

  • A systematic literature search was conducted in PubMed, Web of Science, and Scopus (January 2020 - February 2021).
  • Included studies reported serum cystatin C levels, clinical severity, and survival outcomes in hospitalized COVID-19 patients.
  • Meta-analysis and meta-regression were performed on data from 13 studies involving 2510 patients.

Main Results:

  • Higher serum cystatin C concentrations were significantly associated with increased COVID-19 disease severity and non-survivor status (SMD 1.71, p < 0.001).
  • Extreme heterogeneity was noted across studies (I² = 97.5%), but sensitivity analyses confirmed the robustness of the findings.
  • Meta-regression revealed no association between serum cystatin C levels and various demographic or laboratory parameters, including age, sex, or common comorbidities.

Conclusions:

  • Elevated serum cystatin C levels are a strong indicator of higher severity and mortality in COVID-19 patients.
  • Serum cystatin C shows potential as a valuable biomarker for risk stratification and clinical decision-making in COVID-19 management.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
451
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
262
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.0K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
167